Artivion | CRY - Pre Tax Profit

Stock Price
38.33
Daily Change
0.33 0.87%
Monthly
-13.50%
Yearly
35.63%
Q1 Forecast
37.14

Artivion reported $-1.27M in Pre-Tax Profit for its fiscal quarter ending in September of 2024.





Pre Tax Profit Change Date
Abbott USD 2.36B 178M Dec/2025
Accuray USD 3.23M 6.56M Dec/2024
AngioDynamics USD -4M 1.74M Feb/2025
Artivion USD -1.27M 1.16M Sep/2024
AtriCure USD 2.36M 2.45M Dec/2025
Baxter International USD 121M 12M Sep/2025
Becton, Dickinson and Co. USD 393M 117M Dec/2025
Boston Scientific USD 938M 3M Sep/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Inogen USD -6.06M 467K Sep/2024
Integra LifeSciences USD -6.82M 524.13M Sep/2025
J&J USD 4.97B 2.53B Dec/2025
Mesa Laboratories USD -2.22M 6.03M Dec/2024
Orthofix International USD -123.88M 97.24M Dec/2024
Pfizer USD 3.33B 290M Sep/2025
ResMed USD 482.38M 2.51M Sep/2025
Stryker USD 1.03B 13M Sep/2025
Surmodics USD -7.51M 1.69M Sep/2024
Tandem Diabetes Care USD -25.14M 32.58M Sep/2025
Teleflex USD -438.58M 573.82M Sep/2025
Terumo JPY 45.38B 578M Dec/2025
Trinity Biotech USD -5.06M 10.74M Sep/2025